Figure 6
Figure 6. uPAR−/− neutrophils demonstrate enhanced adhesion to uPAR. (A) Adhesion of uPAR−/− neutrophils to uPAR is increased. A total of 106 viable WT and uPAR−/− neutrophils were added into each well of a 96-well plate precoated with 1 μg/mL BSA or suPAR for 1 hour, and adhesion assays performed as described in “Adhesion assay.” *P < .05. (B) Adhesion of WT neutrophils to uPAR−/− macrophages is increased. A total of 106 viable WT neutrophils were added into each well of a 96-well plate plated with WT and uPAR−/− macrophages, and adhesion assays performed as described in “Adhesion assay.” (C) RGD, but not RAD, peptides, abrogate the enhanced adhesion of uPAR−/− neutrophils to suPAR. uPAR−/− neutrophils were preincubated with 1 μg/mL BSA (con) or 1 μg/mL RGD or RAD peptides for 30 minutes and adhesion assays performed as in panel A. **P < .01. (D) Antibodies to integrins diminish the enhanced adhesion of viable uPAR−/− neutrophils to suPAR. uPAR−/− neutrophils were preincubated with 1 μg/mL mouse IgG or antibodies to the integrins αM, αV, β1, β2, β3, or β4 for 30 minutes. The cells were then resuspended in RPMI 1640 medium and added to suPAR-coated plates for adhesion assays. **P < .01, ***P < .001, compared with the control group treated with control IgG. (E) suPAR and integins are colocalized on the surface of uPAR−/− macrophages. uPAR−/− macrophages were incubated with Chromeo 488–labeled mouse suPAR (1 μg/mL) for 30 minutes. The cells were fixed and then stained overnight without or with antibodies to the integrins αV or β3. Representative confocal images are shown. (F-K) Anti-integrin antibodies prevent the binding of suPAR to the surface of uPAR−/− macrophages. Cells were preincubated without (F,G) or with antibodies (1 μg/mL) to the integrins αV (H), β3 (I), β4 (J), or isotype IgG control (K) for 30 minutes. The cells were then incubated with Chromeo 488–labeled mouse suPAR (1 μg/mL) for 1 hour (G-K) and washed 5 times with PBS. Fluorescent intensity was determined by flow cytometry. (L) uPAR−/− macrophages demonstrate greater Erk phosphorylation after exposure to viable WT neutrophils than do WT macrophages. A total of 4 × 106 viable WT neutrophils were added for the indicated time into each well of a 12-well plate plated with WT or uPAR−/− macrophages. The cells were then collected and the levels of phosphorylated Erk and total Erk determined by Western blot analysis.

uPAR−/− neutrophils demonstrate enhanced adhesion to uPAR. (A) Adhesion of uPAR−/− neutrophils to uPAR is increased. A total of 106 viable WT and uPAR−/− neutrophils were added into each well of a 96-well plate precoated with 1 μg/mL BSA or suPAR for 1 hour, and adhesion assays performed as described in “Adhesion assay.” *P < .05. (B) Adhesion of WT neutrophils to uPAR−/− macrophages is increased. A total of 106 viable WT neutrophils were added into each well of a 96-well plate plated with WT and uPAR−/− macrophages, and adhesion assays performed as described in “Adhesion assay.” (C) RGD, but not RAD, peptides, abrogate the enhanced adhesion of uPAR−/− neutrophils to suPAR. uPAR−/− neutrophils were preincubated with 1 μg/mL BSA (con) or 1 μg/mL RGD or RAD peptides for 30 minutes and adhesion assays performed as in panel A. **P < .01. (D) Antibodies to integrins diminish the enhanced adhesion of viable uPAR−/− neutrophils to suPAR. uPAR−/− neutrophils were preincubated with 1 μg/mL mouse IgG or antibodies to the integrins αM, αV, β1, β2, β3, or β4 for 30 minutes. The cells were then resuspended in RPMI 1640 medium and added to suPAR-coated plates for adhesion assays. **P < .01, ***P < .001, compared with the control group treated with control IgG. (E) suPAR and integins are colocalized on the surface of uPAR−/− macrophages. uPAR−/− macrophages were incubated with Chromeo 488–labeled mouse suPAR (1 μg/mL) for 30 minutes. The cells were fixed and then stained overnight without or with antibodies to the integrins αV or β3. Representative confocal images are shown. (F-K) Anti-integrin antibodies prevent the binding of suPAR to the surface of uPAR−/− macrophages. Cells were preincubated without (F,G) or with antibodies (1 μg/mL) to the integrins αV (H), β3 (I), β4 (J), or isotype IgG control (K) for 30 minutes. The cells were then incubated with Chromeo 488–labeled mouse suPAR (1 μg/mL) for 1 hour (G-K) and washed 5 times with PBS. Fluorescent intensity was determined by flow cytometry. (L) uPAR−/− macrophages demonstrate greater Erk phosphorylation after exposure to viable WT neutrophils than do WT macrophages. A total of 4 × 106 viable WT neutrophils were added for the indicated time into each well of a 12-well plate plated with WT or uPAR−/− macrophages. The cells were then collected and the levels of phosphorylated Erk and total Erk determined by Western blot analysis.

Close Modal

or Create an Account

Close Modal
Close Modal